Samantha Ngo1, Jochen Profit2,3, Jeffrey B Gould2,3, Henry C Lee2,3. 1. School of Public Health, University of California, Berkeley, Berkeley, California; sngo@berkeley.edu. 2. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University, Stanford, California; and. 3. California Perinatal Quality Care Collaborative, Stanford, California.
Abstract
OBJECTIVE: To examine yearly trends of patent ductus arteriosus (PDA) diagnosis and treatment in very low birth weight infants. METHODS: In this retrospective cohort study of very low birth weight infants (<1500 g) between 2008 and 2014 across 134 California hospitals, we evaluated PDA diagnosis and treatment by year of birth. Infants were either inborn or transferred in within 2 days after delivery and had no congenital abnormalities. Intervention levels for treatment administered to achieve ductal closure were categorized as none, pharmacologic (indomethacin or ibuprofen), both pharmacologic intervention and surgical ligation, or ligation only. Multivariable logistic regression was used to assess risk factors for PDA diagnosis and treatment. RESULTS: PDA was diagnosed in 42.8% (12 002/28 025) of infants, with a decrease in incidence from 49.2% of 4205 infants born in 2008 to 38.5% of 4001 infants born in 2014. Pharmacologic and/or surgical treatment was given to 30.5% of patients. Between 2008 and 2014, the annual rate of infants who received pharmacologic intervention (30.5% vs 15.7%) or both pharmacologic intervention and surgical ligation (6.9% vs 2.9%) decreased whereas infants who were not treated (60.5% vs 78.3%) or received primary ligation (2.2% vs 3.0%) increased. CONCLUSIONS: There is an increasing trend toward not treating patients diagnosed with PDA compared with more intensive treatments: pharmacologic intervention or both pharmacologic intervention and surgical ligation. Possible directions for future study include the impact of these trends on hospital-based and long-term outcomes.
OBJECTIVE: To examine yearly trends of patent ductus arteriosus (PDA) diagnosis and treatment in very low birth weight infants. METHODS: In this retrospective cohort study of very low birth weight infants (<1500 g) between 2008 and 2014 across 134 California hospitals, we evaluated PDA diagnosis and treatment by year of birth. Infants were either inborn or transferred in within 2 days after delivery and had no congenital abnormalities. Intervention levels for treatment administered to achieve ductal closure were categorized as none, pharmacologic (indomethacin or ibuprofen), both pharmacologic intervention and surgical ligation, or ligation only. Multivariable logistic regression was used to assess risk factors for PDA diagnosis and treatment. RESULTS: PDA was diagnosed in 42.8% (12 002/28 025) of infants, with a decrease in incidence from 49.2% of 4205 infants born in 2008 to 38.5% of 4001 infants born in 2014. Pharmacologic and/or surgical treatment was given to 30.5% of patients. Between 2008 and 2014, the annual rate of infants who received pharmacologic intervention (30.5% vs 15.7%) or both pharmacologic intervention and surgical ligation (6.9% vs 2.9%) decreased whereas infants who were not treated (60.5% vs 78.3%) or received primary ligation (2.2% vs 3.0%) increased. CONCLUSIONS: There is an increasing trend toward not treating patients diagnosed with PDA compared with more intensive treatments: pharmacologic intervention or both pharmacologic intervention and surgical ligation. Possible directions for future study include the impact of these trends on hospital-based and long-term outcomes.
Authors: Valerie Y Chock; Rajesh Punn; Anushri Oza; William E Benitz; Krisa P Van Meurs; Alice S Whittemore; Fariborz Behzadian; Norman H Silverman Journal: Pediatr Res Date: 2013-12-30 Impact factor: 3.756
Authors: Sophia M Ansems; Haresh Kirpalani; Laura Mercer-Rosa; Yan Wang; Rachel K Hopper; María V Fraga; Erik A Jensen Journal: Neonatology Date: 2019-07-03 Impact factor: 4.035
Authors: Shannon E G Hamrick; Hannes Sallmon; Allison T Rose; Diego Porras; Elaine L Shelton; Jeff Reese; Georg Hansmann Journal: Pediatrics Date: 2020-11 Impact factor: 7.124
Authors: Merete S Engeseth; Mette Engan; Hege Clemm; Maria Vollsæter; Roy M Nilsen; Trond Markestad; Thomas Halvorsen; Ola D Røksund Journal: Front Pediatr Date: 2020-04-08 Impact factor: 3.418
Authors: Thowfique Ibrahim; Abdul Alim Abdul Haium; Sarah Jane Tapawan; Rowena Dela Puerta; John C Allen; Suresh Chandran; Mei Chien Chua; Victor Samuel Rajadurai Journal: Front Pediatr Date: 2021-01-28 Impact factor: 3.418
Authors: Esther J S Jansen; Tim Hundscheid; Wes Onland; Elisabeth M W Kooi; Peter Andriessen; Willem P de Boode Journal: Front Pediatr Date: 2021-02-09 Impact factor: 3.418
Authors: Tim Hundscheid; Esther J S Jansen; Wes Onland; Elisabeth M W Kooi; Peter Andriessen; Willem P de Boode Journal: Front Pediatr Date: 2021-02-25 Impact factor: 3.418
Authors: Tim Hundscheid; Wes Onland; Bart van Overmeire; Peter Dijk; Anton H L C van Kaam; Koen P Dijkman; Elisabeth M W Kooi; Eduardo Villamor; André A Kroon; Remco Visser; Daniel C Vijlbrief; Susanne M de Tollenaer; Filip Cools; David van Laere; Anne-Britt Johansson; Catheline Hocq; Alexandra Zecic; Eddy Adang; Rogier Donders; Willem de Vries; Arno F J van Heijst; Willem P de Boode Journal: BMC Pediatr Date: 2018-08-04 Impact factor: 2.125